We now explicitly state that further functional studies, including in vitro and in vivo models, are needed to confirm these mechanistic links and to clarify whether TrkA exerts a causal role in tumor suppression or reflects a more differentiated tumor phenotype [23]. This evidence concerns the gene NTRK1 and neoplasm.